8-39755898-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001464.5(ADAM2):c.1627G>A(p.Gly543Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000216 in 1,527,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001464.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAM2 | ENST00000265708.9 | c.1627G>A | p.Gly543Arg | missense_variant | Exon 16 of 21 | 1 | NM_001464.5 | ENSP00000265708.4 | ||
ADAM2 | ENST00000347580.8 | c.1570G>A | p.Gly524Arg | missense_variant | Exon 15 of 20 | 1 | ENSP00000343854.4 | |||
ADAM2 | ENST00000379853.6 | c.1236-77G>A | intron_variant | Intron 11 of 16 | 1 | ENSP00000369182.2 | ||||
ADAM2 | ENST00000521880.5 | c.1608+5283G>A | intron_variant | Intron 15 of 19 | 2 | ENSP00000429352.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151906Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000249 AC: 6AN: 241200Hom.: 0 AF XY: 0.0000383 AC XY: 5AN XY: 130572
GnomAD4 exome AF: 0.0000218 AC: 30AN: 1376028Hom.: 0 Cov.: 24 AF XY: 0.0000247 AC XY: 17AN XY: 687878
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151906Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74188
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1627G>A (p.G543R) alteration is located in exon 16 (coding exon 16) of the ADAM2 gene. This alteration results from a G to A substitution at nucleotide position 1627, causing the glycine (G) at amino acid position 543 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at